In the wake of its planned acquisition of Personal Chemistry, Pyrosequencing has appointed a new management team: Hans Johansson, currently president of Personal Chemistry, will become president and COO of Pyrosequencing; Mats-Olof Wallin and Marten Winge will continue as CFO and vice president of marketing, respectively; Jon-Sverre Schanche, currently vice president of R&D at Personal Chemistry, will be vice president of R&D; Scott Carr, head of Personal Chemistry’s US sales company, will become president of the merged US subsidiaries.
Erik Wallden, currently the president of Pyrosequencing, has “requested to be relieved from his duties,” the company said. Pyrosequencing said he will leave the company on Sept. 25, when the Personal Chemistry acquisition is scheduled to close. Meantime, Jeff Bork will continue as chairman of the board and CEO.
David Danley, a retired US Army Colonel, has joined CombiMatrix as director of homeland security and defense programs. He will head efforts to develop products for agents of detection of biological and chemical warfare.
Danley joins the Acacia Research subsidiary after retiring from the US armed services in early August. Most recently he was project manager of the Chemical Biological Medical Systems and Joint Vaccine Acquisition Program for the Department of Defense, where he led efforts to develop new vaccines against anthrax, smallpox, and other biological agents.
Prior to holding this post, Danley was commander of the US Army Center for Environmental Health Research, where he led development and evaluation of sensors for toxic compounds. He was also assistant program manager for the Joint Program Office for Biological Defense.